EDWARDS SAPIEN 3? TRANSCATHETER HEART VALVE, 29 MM 9600TFX29

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2020-03-20 for EDWARDS SAPIEN 3? TRANSCATHETER HEART VALVE, 29 MM 9600TFX29 manufactured by Edwards Lifesciences.

Event Text Entries

[184414022] The edwards sapien 3 transcatheter heart valve, model 9600tfx, and accessories are indicated for patients with symptomatic heart disease due to failure (stenosed, insufficient, or combined) of a surgical bioprosthetic aortic or mitral valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i. E. , predicted risk of surgical mortality = 8% at 30 days, based on the sts risk score and other clinical co-morbidities unmeasured by the sts risk calculator). Obstruction of the left ventricular outflow tract can be caused by patient factors (anterior mitral leaflet protruding into the lvot, septal bulge) or procedural factors (positioning of the valve frame within the annulus). Depending on the degree of obstruction, cardiac output and hemodynamic stability may be affected. Inaccurate deployment is generally a result of use error or a combination or patient and procedural factors. In some cases lvot obstruction could result in clinically significant hemodynamic compromise that may require explanation of the thv with surgical correction. In this case, there was no allegation or indication a device malfunction contributed to this adverse event. The cause of the lvot obstruction and subsequent hemolysis resulting in the patient death, was due to patient factors (protrusion of the septum in the lvot. ) the ifu and training manuals have been reviewed and no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device. Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review. No corrective or preventative actions are required at this time.
Patient Sequence No: 1, Text Type: N, H10


[184414023] As reported, a 29mm sapien 3 valve was implanted within an edwards annuloplasty ring in the mitral position through transseptal approach. The valve in ring was performed with resulting mild pvl leak however, there was an lvot obstruction caused by a protrusion of the septum in the lvot. An alcohol septal ablation was performed to resolve this issue. The patient did well 24hrs hours post procedure but then developed hemolysis causing multiple organ failure and subsequently passed away.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2015691-2020-11076
MDR Report Key9862796
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2020-03-20
Date of Report2020-02-26
Date of Event2020-02-13
Date Mfgr Received2020-02-26
Device Manufacturer Date2019-07-07
Date Added to Maude2020-03-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. FRANCES PRESTON
Manufacturer Street1 EDWARDS WAY
Manufacturer CityIRVINE CA 92614
Manufacturer CountryUS
Manufacturer Postal92614
Manufacturer Phone9492505190
Manufacturer G1EDWARDS LIFESCIENCES LLC
Manufacturer Street1 EDWARDS WAY
Manufacturer CityIRVINE CA 92614
Manufacturer CountryUS
Manufacturer Postal Code92614
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameEDWARDS SAPIEN 3? TRANSCATHETER HEART VALVE, 29 MM
Generic NamePROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED
Product CodeNPU
Date Received2020-03-20
Model Number9600TFX29
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerEDWARDS LIFESCIENCES
Manufacturer Address1 EDWARDS WAY IRVINE CA 92614 US 92614


Patients

Patient NumberTreatmentOutcomeDate
101. Death; 2. Required No Informationntervention 2020-03-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.